این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
Middle East Journal of Cancer، جلد ۱۶، شماره ۳، صفحات ۱۹۷-۲۰۹
عنوان فارسی
چکیده فارسی مقاله
کلیدواژه‌های فارسی مقاله
عنوان انگلیسی Comparison Anticancer Effects of Platinum Ribavirin with Platinum Azidothymidine via Telomerase, Bcl-2, miRNA-21 and miRNA-122 Biomarkers Genes Expression on HepG2 Cancer Cell Lines
چکیده انگلیسی مقاله Background: Anticancer medication assessment is performed by numerous approaches including biomarkers gene expression. This study aimed to investigate the anticancer effects of Pt-Rb and Pt-AZTon HepG2 cells. 
Method: In this case-control study, four groups of cells were examined. Group A was the control group, group B was untreated cancer cells, and Groups C and D were treated with Pt-AZT and Pt-Rb, respectively. Using the MTT test, LC50 was determined, and the relative gene expression of the biomarkers was assessed by RNA extraction, cDNA synthesis and RT-PCR. Through histopathlogical study apoptotic regions of cells were compared. Data analysis was done using ANOVA and Turkey’s post hoc test.
Results: The results showed a significant increase for the proapoptotic gene miRNA-122 (19.97 ± 0 .04) in group D compared with group C (10.36 ± 0.007). Also, there was a significant decrease in the antiapoptotic genes in group D, including miRNA-21 (0.10 ± 0.014), telomerase (0.56 ± 0.480), and Bcl-2 (0.41 ± 0.276), compared with group C (miRNA-21: 2.0 ± 0.145, telomerase: 2.49 ± 0.231, and Bcl-2: 2.93 ± 0.276). There were significant differences between the nearly all studied groups (P < 0.05). There were more extensive apoptotic regions in group D compared with group C.
Conclusion: Using Pt-Rb has more benefits in terms of stronger anticancer effects than Pt-AZT on cancer cells. Also, lower drug resistance and lower side effects in Pt-Rb were considered compared with Pt-AZT, indicating that it can be more effective in anti-cancer therapy.
کلیدواژه‌های انگلیسی مقاله miRNAs,Platinum compounds,HepG2 cells,Telomerase
نویسندگان مقاله Abdolreza Sabokrouh |
Department of Biochemistry, Faculty of Medicine, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran

Nasim Ghaffari |
Department of Biochemistry and Biophysics, Faculty of Advanced Sciences and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran

Soheila Hajivand |
Department of Biochemistry and Biophysics, Faculty of Advanced Sciences and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran

Fereshteh Atabi |
Department of Biochemistry and Biophysics, Faculty of Advanced Sciences and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran

Reza Saghiri |
Department of Biochemistry, Pasteur institute, Tehran, Iran

Zohreh Sharifi |
Blood Transfusion Research center, High institute for Research and Education in Transfusion Medicine, Tehran, Iran

نشانی اینترنتی https://mejc.sums.ac.ir/article_50655_73975af7cdd239c4f9621142acfb7694.pdf
فایل مقاله فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده en
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده
برگشت به: صفحه اول پایگاه   |   نسخه مرتبط   |   نشریه مرتبط   |   فهرست نشریات